We are live on ! Find out more
NXTC icon

NextCure
NXTC

45 hedge funds and large institutions have $18.4M invested in NextCure in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.56% less ownership

Funds ownership: 4.58% → 4.02% (-0.56%)

13% less funds holding

Funds holding: 52 → 45 (-7)

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

46% less capital invested

Capital invested by funds: $34.3M → $18.4M (-$15.9M)

54% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 13

Holders
45
Holders Change
-7
Holders Change %
-13.46%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
16
Closed
13
Calls
$156K
Puts
–
Net Calls
+$156K
Net Calls Change
-$269K

Top Buyers

Rank Fund Capital Flow
1
CPA
Cardiff Park Advisors
California
+$502K
2
Renaissance Technologies
Renaissance Technologies
New York
+$339K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$249K
4
Millennium Management
Millennium Management
New York
+$233K
5
BCM
Bridgeway Capital Management
Texas
+$172K

Top Sellers

Rank Fund Capital Flow
1
KPF
K2 Principal Fund
Ontario, Canada
-$4.19M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$617K
3
BlackRock
BlackRock
New York
-$384K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$290K
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$264K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$3.82M – – –
SI
2
Sofinnova Investments
California
$3.77M – – –
Millennium Management
3
Millennium Management
New York
$1.89M +$233K +10,124 +10%
BlackRock
4
BlackRock
New York
$1.48M -$384K -16,675 -16%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.28M +$621 +27 +0%
LFCM
6
Long Focus Capital Management
Puerto Rico
$784K – – –
Citadel Advisors
7
Citadel Advisors
Florida
$736K +$92.2K +4,006 +10%
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$605K +$249K +10,819 +43%
Renaissance Technologies
9
Renaissance Technologies
New York
$573K +$339K +14,715 +77%
Federated Hermes
10
Federated Hermes
Pennsylvania
$549K -$261K -11,366 -26%
Goldman Sachs
11
Goldman Sachs
New York
$437K -$51K -2,216 -8%
CPA
12
Cardiff Park Advisors
California
$369K +$502K +21,833 New
DCM
13
DAFNA Capital Management
California
$265K – – –
Geode Capital Management
14
Geode Capital Management
Massachusetts
$237K -$621 -27 -0.2%
Macquarie Group
15
Macquarie Group
Australia
$212K – – –
BCM
16
Bridgeway Capital Management
Texas
$204K +$172K +7,492 +164%
Two Sigma Advisers
17
Two Sigma Advisers
New York
$201K -$20.9K -909 -7%
SCM
18
Sio Capital Management
New York
$183K – – –
Barclays
19
Barclays
United Kingdom
$95.3K -$1.01K -44 -0.8%
State Street
20
State Street
Massachusetts
$80.5K – – –
Norges Bank
21
Norges Bank
Norway
$73.2K – – –
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$67.6K +$91.9K +3,996 New
Northern Trust
23
Northern Trust
Illinois
$60.4K -$1.06K -46 -1%
ECM
24
ExodusPoint Capital Management
New York
$49K -$28.2K -1,225 -30%
Two Sigma Investments
25
Two Sigma Investments
New York
$47.7K -$55.9K -2,431 -46%
1
2 3

NXTC Hedge Fund Activity: Q4 2022 in Review

45 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q4 2022, worth a combined $18.4M — down 46% from $34.3M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of NXTC and 6 opened new positions — a net loss of 7 holders — while 16 trimmed existing stakes and 9 added.

The largest buyer was Cardiff Park Advisors, opening a new position worth an estimated $502K. The largest seller was K2 Principal Fund, exiting entirely with an estimated $4.19M sold.

  • 45 institutional investors held NextCure (NXTC) as of Q4 2022, down from 52 in Q3 2022.
  • Funds reported $18.4M of NextCure stock for Q4 2022, down 46% quarter-over-quarter.
  • 6 funds opened new NextCure positions in Q4 2022 and 13 closed out, a net change of -7 holders.
  • The largest NextCure buyer in Q4 2022 was Cardiff Park Advisors, an estimated $502K added.
  • The largest NextCure seller in Q4 2022 was K2 Principal Fund, an estimated $4.19M sold.

Based on aggregated 13F filings for Q4 2022.